Musk Blows Up Online as ‘Ketamine’ Dinner Clip Resurfaces
The billionaire issued his most frustrated denial yet amid rumors of rampant drug use.

Photo Illustration by Eric Faison/The Daily Beast/Getty Images
Elon Musk issued a curt rebuke of ketamine abuse allegations after a viral clip of his erratic behavior at a dinner recirculated online.
The clip—taken in March during a visit to President Donald Trump’s Bedminster golf club in New Jersey—shows Musk balancing spoons at a dinner table while one of his baby mamas, Shivon Zilis, watches in silent concern.
At the time, X user and “retired army medic” Molly Ploofkins tweeted the clip with the caption, “Musk playing with his silverware while tripping on ketamine at Bedminster.”
Musk playing with his silverware while tripping on ketamine at Bedminster.pic.twitter.com/2nvI7Wzuri
— Molly Ploofkins (@Mollyploofkins) March 22, 2025
Amid an explosive New York Times report accusing Musk of using drugs as his Department of Government Efficiency bulldozed its way across the federal government, computer scientist and writer Paul Graham attempted to normalize the clip with a tweet insisting that he does the same with his silverware.
Responding to the original clip, Graham tweeted, “You don’t need ketamine to make these. I always make them. In our family we call them ‘Robert towers,’ after Robert Morris, who also makes them.”
Get the best of The Beast delivered right to your inbox
By clicking “SUBSCRIBE” you agree to our Terms of Use and Privacy Policy.
The remark elicited a visceral response from Musk: “I’m not on ketamine ffs,” he wrote.
I’m not on ketamine ffs
— Elon Musk (@elonmusk) May 31, 2025
Graham responded under his comment, “That’s what I’m saying. Making cutlery towers isn’t evidence that someone’s on drugs. You could take an identical video of me at a dinner.”
As Trump bid adieu to Musk in a Friday press conference—in which the president insisted “Elon is not really leaving”—the Tesla CEO shut down questions about the Times report.
“Is The New York Times the same publication that got a Pulitzer Prize for false reporting on Russiagate—is it the same organization?” Musk said. “I think the judge just ruling against The New York Times for their lies about the Russiagate hoax and that they might have to give back that Pulitzer Prize. That New York Times? Let’s move on!”

Elon Musk shook hands with President Donald Trump as he prepared to leave the White House after a four-month stint as a special government employee, where he lead the Department of Government Efficiency (DOGE)'s mission to slash government spending.
Kevin Dietsch/Kevin DIetsch/Getty Images
Yet Musk’s fierce denials contradict what he has publicly said and tweeted about using ketamine to counter his “brain chemistry.”
In a tweet posted Aug. 4, 2023, Musk responded to Nigerian rapper Zuby’s concerns about antidepressants with his own take.
“I have serious concerns about SSRIs, as they tend to zombify people,” he wrote. “Occasional use of Ketamine is a much better option, in my opinion. I have a prescription for when my brain chemistry sometimes goes super negative.”
“SSRIs” refers to “selective serotonin reuptake inhibitors,” the class of antidepressants that includes Prozac and Zoloft.
I have serious concerns about SSRIs, as they tend to zombify people.
— Elon Musk (@elonmusk) August 5, 2023
Occasional use of Ketamine is a much better option, in my opinion. I have a prescription for when my brain chemistry sometimes goes super negative.
Musk echoed such sentiments again a year later in an interview with journalist Don Lemon, admitting to the former CNN host that he takes a “small amount” of ketamine to treat depression.
“There are times when I have a sort of ... negative chemical state in my brain,” he explained. “Ketamine is helpful for getting one out of a negative frame of mind.”
Unlock a year of full access to The Looker and The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.
Register below to read this article for free or subscribe
to unlock unlimited access to The Looker and The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.
Sign in
Login dialog


